Cargando…

Tixagevimab and Cilgavimab (Evusheld) as Pre-exposure Prophylaxis for COVID-19 in Patients With Inflammatory Bowel Disease: A Propensity Matched Cohort Study

BACKGROUND: Tixagevimab and cilgavimab (Evusheld) are 2 fully human monoclonal antibodies that received emergency-use authorization on December 21, 2021, for pre-exposure prophylaxis of coronavirus disease 2019 (COVID-19) in patients who are moderate–severely immunocompromised. The real-world effica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Desai, Aakash, Hashash, Jana G, Kochhar, Gursimran S, Farraye, Francis A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Fellows' Corner
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482141/ https://www.ncbi.nlm.nih.gov/pubmed/37680248 http://dx.doi.org/10.1093/crocol/otad047

Ejemplares similares

Efficacy of Paxlovid and Lagevrio for COVID-19 Infection in Patients With Inflammatory Bowel Disease: A Propensity-Matched Study
por: Hashash, Jana G., et al.
Publicado: (2023)

Real world effectiveness of tixagevimab/cilgavimab (Evusheld) in the Omicron era
por: Chen, Benjamin, et al.
Publicado: (2023)

Pre-exposure prophylaxis with tixagevimab and cilgavimab (Evusheld) for COVID-19 among 1112 severely immunocompromised patients
por: Nguyen, Yann, et al.
Publicado: (2022)

P57 PRE-EXPOSURE PROPHYLAXIS FOR COVID-19 WITH TIXAGEVIMAB/CILGAVIMAB (EVUSHELD) IN PATIENTS WITH MULTIPLE MYELOMA
por: Ntanasis-Stathopoulos, I., et al.
Publicado: (2023)

Real-World Effectiveness of Tixagevimab and Cilgavimab (Evusheld) in Patients With Hematological Malignancies
por: Ocon, Anthony J., et al.
Publicado: (2022)

Safety and efficacy of pre-exposure prophylaxis with tixagevimab/cilgavimab (Evusheld) in patients with glomerular diseases who received rituximab
por: Sciascia, Savino, et al.
Publicado: (2023)

Tixagevimab and Cilgavimab (Evusheld) in Rituximab-treated Antineutrophil Cytoplasmic Antibody Vasculitis Patients
por: Aqeel, Faten, et al.
Publicado: (2022)

P1574: EFFICACY AND SAFETY OF TIXAGEVIMAB AND CILGAVIMAB (EVUSHELD) IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
por: Aleshina (Gavrilina), Olga, et al.
Publicado: (2023)

Tixagevimab and Cilgavimab (Evusheld – AstraZeneca) efficacy in preventing COVID infection in immunocompromised patients
por: Miot, Christelle, et al.
Publicado: (2023)

A Critical Analysis of the Use of Cilgavimab plus Tixagevimab Monoclonal Antibody Cocktail (Evusheld™) for COVID-19 Prophylaxis and Treatment
por: Focosi, Daniele, et al.
Publicado: (2022)

Tixagevimab and Cilgavimab (Evusheld™) Prophylaxis Prevents Breakthrough COVID-19 Infections in Immunosuppressed Population: 6-Month Prospective Study
por: Jakimovski, Dejan, et al.
Publicado: (2023)

Tixagevimab and cilgavimab for COVID-19 prophylaxis
Publicado: (2022)

‘Real-World’ Impact of Tixagevimab/Cilgavimab (Evusheld) on COVID-19 Outcomes in Patients Undergoing Cellular Therapies
por: Sannareddy, Aishwarya, et al.
Publicado: (2023)

SARS-CoV-2 infection in high-risk children following tixagevimab–cilgavimab (Evusheld) pre-exposure prophylaxis: a single-center observational study
por: Hijano, Diego R., et al.
Publicado: (2023)

Tixagevimab and Cilgavimab (Evusheld) Boosts Antibody Levels to SARS-Cov-2 in Patients with Multiple Sclerosis on B-Cell Depleters
por: Conte, William L., et al.
Publicado: (2023)

(701) Use of Tixagevimab and Cilgavimab (Evusheld) and Subsequent Outcomes of SARS-CoV-2 Infections in Lung Transplant Recipients
por: Grillini, A., et al.
Publicado: (2023)

Tixagevimab/Cilgavimab Pre-exposure Prophylaxis in Patients With Lymphoproliferative Disorders on BTKi
por: Zamprogna, Giulia, et al.
Publicado: (2023)

Tixagevimab and Cilgavimab (Evusheld) boosts antibody levels to SARS-CoV-2 in patients with multiple sclerosis on b-cell depleters
por: Conte, William L., et al.
Publicado: (2022)

Hip Fracture Trends in America Between 2009 and 2016
por: Remily, Ethan A., et al.
Publicado: (2020)

Finding hope amidst a pandemic
por: Singh, Vasvi
Publicado: (2020)

Cardiovascular disease training lessons learned during the COVID-19 pandemic: Need for change in training paradigm
por: Gangadharamurthy, Dakshin
Publicado: (2020)

It’s a small world after all: A Canadian resident’s perspective on COVID-19
por: Sutherland, Duncan E. K.
Publicado: (2020)

Frailty and Sarcopenia in Patients With Distal Radius Fracture: A Geriatric Perspective
por: Caliskan, Hatice, et al.
Publicado: (2020)

Leading by example: Experiences and lessons learned from ASNC’s Future Leaders of Nuclear Cardiology Symposium
por: Lehenbauer, Kyle
Publicado: (2021)

A cardiology fellow’s take-home points from ASNC’s Webinar: Cases in Tc 99m-PYP evaluation of ATTR cardiac amyloidosis - interpretation and reporting
por: Shetty, Mrinali
Publicado: (2021)

Preoperative Cognitive Impairment as a Perioperative Risk Factor in Patients Undergoing Total Knee Arthroplasty
por: Krishnan, Sindhu, et al.
Publicado: (2021)

Introducing the all-new Fellows Corner of Heart Rhythm O(2): The future is here now
por: Kutyifa, Valentina
Publicado: (2022)

Beware of superior vena cava isolation during cryoballoon ablation of the right superior pulmonary vein
por: Bergonti, Marco, et al.
Publicado: (2022)

A zebra masquerading as a horse: A case of bundle-branch reentrant ventricular tachycardia
por: Jawaid, Anas, et al.
Publicado: (2022)

Anterior mitral line pseudo-block: Pitfalls of the atrial differential pacing maneuver
por: Bergonti, Marco, et al.
Publicado: (2022)

Cardiogenic shock due to arrhythmia-induced cardiomyopathy and its recovery after radiofrequency ablation under extracorporeal membrane oxygenation support
por: Sanhueza, Sebastian, et al.
Publicado: (2022)

Hyperviscosity syndrome revisited
por: Gangopadhyay, Debasree, et al.
Publicado: (2022)

Right-sided subcutaneous implantable cardioverter-defibrillator placement in a patient with “acquired mesocardia”
por: Prousi, George S., et al.
Publicado: (2022)

Diagnostic decapolar catheter entrapment in the coronary sinus: A rare complication of electrophysiology procedures
por: Tu, Samuel J., et al.
Publicado: (2023)

Higher Mortality Rate in Patients with Vertebral Compression Fractures is due to Deteriorated Medical Status Prior to the Fracture Event
por: Zohar, Ariel, et al.
Publicado: (2023)

Delay to Surgical Treatment in Geriatric Hip Fracture Patients
por: Joseph, Elias G., et al.
Publicado: (2023)

When logic fails
por: Phan, Justin, et al.
Publicado: (2023)

Mobility and Hip Function Among Geriatric Patients With Displaced Neck of Femur Fractures Treated With Arthroplasty
por: Ho, Jade Pei Yuik, et al.
Publicado: (2023)

Catheter ablation for persistent atrial fibrillation in a patient with extensive lipomatous hypertrophy of the atrial septum: 3D electroanatomic mapping for ideal procedure planning and performance in abnormal atrial anatomy
por: Krafft, Hannah, et al.
Publicado: (2023)

COVID-19 breakthrough infections and sleep disorders: A population-based propensity matched analysis
por: Punj, Mantavya, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_18cessbh6ld6c0025o8p9fanl0